Concepedia

Sarah Spreckelmeyer

SS

Statistics

Publications

11

Citations

332

H-Index

11

Active since

2015

Affiliations

Charité - Universitätsmedizin Berlin(Current)

Humboldt-Universität zu Berlin

University of British Columbia

Freie Universität Berlin

University of Groningen

Sarah Spreckelmeyer is an author at Charité - Universitätsmedizin Berlin specializing in medicinal chemistry, natural sciences, and drug discovery.

ORCID

Top concepts

Publications per year

2015–2023

11

Publications

11

Exploring the potential of gold(<scp>iii</scp>) cyclometallated compounds as cytotoxic agents: variations on the C^N theme

Benoı̂t Bertrand, Sarah Spreckelmeyer, Ewen Bodio et al. · Dalton Transactions · 2015 · 68 citations · Full text

Rhodium(I) N-Heterocyclic Carbene Bioorganometallics as in Vitro Antiproliferative Agents with Distinct Effects on Cellular Signaling

Luciano Oehninger, Sarah Spreckelmeyer, Pavlo Holenya et al. · Journal of Medicinal Chemistry · 2015 · 46 citations

, , +18

Fully-automated production of [68Ga]Ga-FAPI-46 for clinical application

Sarah Spreckelmeyer, M. Balzer, Simon Poetzsch et al. · EJNMMI Radiopharmacy and Chemistry · 2020 · 43 citations · Full text

<i>p</i>-NO<sub>2</sub>–Bn–H<sub>4</sub>neunpa and H<sub>4</sub>neunpa–Trastuzumab: Bifunctional Chelator for Radiometalpharmaceuticals and <sup>111</sup>In Immuno-Single Photon Emission Computed Tomography Imaging

Sarah Spreckelmeyer, Caterina F. Ramogida, Julie Rousseau et al. · Bioconjugate Chemistry · 2017 · 42 citations · Full text

Thorium chelators for targeted alpha therapy: Rapid chelation of thorium‐226

Maryline G. Ferrier, Yawen Li, Ming‐Kuan Chyan et al. · Journal of Labelled Compounds and Radiopharmaceuticals · 2020 · 29 citations · Full text

1–5 of 11